* Download comes with a free subscription to our newsletter. You can unsubscribe any time. You will not get duplicate emails if you download more than one report.

  1. 1

FTA:

Intermittent dosing with rapamycin breaks the inflammatory loop associated with senescence, scientists report. Once disrupted, it takes time for the loop to reestablish itself – providing proof-of-principal that intermittent dosing could provide a way to reap the benefits of rapamycin while bypassing its safety issues. The FDA-approved drug increases healthspan and lifespan in mice.

  1. You must first login , or register before you can comment.

    Markdown formatting available